Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.

AMSBIO - Animal-Free Enzymes for In-Vitro Tissue Dissociation

AMSBIO, in association with Nordmark Biochemicals, is now offering animal-free Collagenase and Neutral Protease enzymes, isolated from Clostridium histolyticum, for in vitro tissue dissociation leading to high yields of viable cells.

Read the rest of entry »

AMSBIO - Cytosections for Antibody Screening and Immunohistochemistry Protocol Development

AMSBIO has launched a comprehensive range of cytosections that offer a verified, reproducible and renewable source of positive / negative controls where the expression of the target biomarker is confirmed for accuracy and specificity by an immunoassay.

Read the rest of entry »

Midven: Future Planet Capital acquires Midven Ltd, one of the UK’s oldest venture capital firms

London, UK, 8th April 2021 / Sciad Newswire / Future Planet Capital (FPC) has announced its acquisition of one of Britain’s most respected venture capital firms, Midven Ltd. The deal will enable Future Planet to grow its extensive global innovation network, which includes Berkeley, Cambridge, Harvard, MIT and Oxford, by combining them with Midven’s access to top-ranked UK Government funded scientific research. FPC is already a leader in this sector and was one of the first to bring sovereign wealth fund investors to British university venture.

Read the rest of entry »

Yourgene: Approved provider of day two and day eight coronavirus testing for international arrivals, for both PCR and sequencing

Manchester, UK – 29 March 2021: Yourgene (AIM: YGEN), the international molecular diagnostics group, announces that Yourgene Genomic Services COVID-19 testing services have been approved by the Department of Health and Social Care (DHSC). Yourgene has been added to the UK Government’s approved list as a private provider of day two and day eight coronavirus testing for all international arrivals1for both SARS-CoV-2 PCR testing and SARS-CoV-2 genome sequencing testing services.

Read the rest of entry »

OBN and its Investment & Tax Special Interest Group (ITSIG) issues an Open Letter to the Chancellor for a better deal for the Life Sciences sector

OBN and its Investment & Tax Special Interest Group (ITSIG) issues an Open Letter to the Chancellor for a better deal for the Life Sciences sector:


Read the rest of entry »

University of Birmingham Enterprise: Rugby study identifies new method to diagnose concussion using saliva

March 24, 2021:  A University of Birmingham-led study of top-flight UK rugby players - carried out in collaboration with the Rugby Football Union (RFU), Premiership Rugby, and Marker Diagnostics - has identified a method of accurately diagnosing concussion using saliva, paving the way for the first non-invasive clinical test for concussion for use in sport and other settings.

Read the rest of entry »

Samsara takes new lab space at The Oxford Trust’s Wood Centre for Innovation

Biotech start-up, Samsara Therapeutics, is the first company to take new laboratory space at The Oxford Trust’s Wood Centre for Innovation. The Trust, a local charity encouraging the pursuit of science and enterprise, is developing life science laboratories at its Wood Centre for Innovation to increase capacity for the local ecosystem. 

Read the rest of entry »

Hayes Parsons - Intellectual Property: Insurance Overview

Intellectual Property (IP) refers to creations of the mind, such as inventions, literary and artistic works, designs and symbols, names and images. For businesses focused on innovation and the importance of their brand, protecting this IP is crucial. IP can also be infringed, if a third party disputes the use and ownership of a creation.

Read the rest of entry »

Inivata to Present New Data in Support of its RaDaR™ MRD and InVisionFirst®-Lung tests at AACR Virtual Annual Meeting 2021

Research Triangle Park, NC, USA and Cambridge, UK, 17 March 2021 -- Inivata, a leader in liquid biopsy, will present new data on its RaDaR assay for the detection of molecular residual disease (MRD) and recurrence at the American Association for Cancer Research (AACR) Virtual Annual Meeting, taking place on 10-15 April 2021. Data on the Company’s InVisionFirst-Lung liquid biopsy test will also be presented.

Read the rest of entry »

AMSBIO : GMP-Ready Helper Plasmids for AAV Production

Manufactured in dedicated clean-rooms with mandated changeovers before new production cycles - AMSBIO introduces new pHelper-Kan plasmid DNA optimized for Adeno-Associated Virus (AAV) manufacturing.

Read the rest of entry »

Pages: Previous1234567...29NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.